CTOs on the Move

The Media Matters

www.tmm.agency

 
At The Media Matters we believe in partnership. Whether it is with our clients, our media contacts, our vendors, or our internal team, we are all in this together. We appreciate those with whom we choose to work and it shows in the level of commitment and creativity we bring forth for them. We respect the relationships we have built through the years and it shows. One of our clients recently commented, You have the best rolodex in the business. That`s because people know us, like us, want to work with us, and value what we bring to the party. ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tmm.agency
  • 210 Sapona Drive
    Lexington, NC USA 27295
  • Phone: 336.956.2488

Executives

Name Title Contact Details

Similar Companies

Manassas Travel Inc

Manassas Travel Inc is a Manassas, VA-based company in the Business Services sector.

Nottingham

Since 1989, Nottingham has been providing structural and operational solutions for mutual funds, private funds and other pooled investment vehicles including, foundations, endowments, and government investment pools. We specialize in turnkey fund organization, accounting and portfolio record keeping services. Our consultative approach works to create the best solution for your organization. Nottingham`s customized solutions are designed to allow you to focus resources on the core aspects of your business. Our accountants, transfer agents, shareholder representatives and IT professionals are dedicated to the success of every investment structure we handle.

Ec Enterprises

Ec Enterprises is a Omaha, NE-based company in the Business Services sector.

Cellerant

Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.

Action R V

Action R V is a Albuquerque, NM-based company in the Business Services sector.